Immuneering Corporation
USD4.28
-0.21 (-4.78%)
CEO
Benjamin J. Zeskind
IPO Date
2021-07-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.59
Prev. Close
$4.50
Day Low
$4.24
Day High
$4.59
52W Low
$1.66
52W High
$10.08
Market Cap
$0.16B
Volume
2.49M
| 176,000 |
| $4.91 |
| 5 Feb 2026 | Brakewood Harold Eugene | Chief Business Officer | A-Award | Acquired | 140,000 | $4.91 |
| 5 Feb 2026 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | A-Award | Acquired | 344,000 | $4.91 |
| 5 Feb 2026 | Matushansky Igor | Chief Medical Officer | A-Award | Acquired | 140,000 | $4.91 |
| 5 Feb 2026 | Morales Mallory | SVP Finance, CAO | A-Award | Acquired | 140,000 | $4.91 |
| 5 Feb 2026 | Neufeld Leah R | CHIEF PEOPLE OFFICER | A-Award | Acquired | 140,000 | $4.91 |
| 5 Feb 2026 | Zeskind Benjamin J. | director, officer: PRESIDENT AND CEO | A-Award | Acquired | 688,000 | $4.91 |
| 21 Jan 2026 | Brakewood Harold Eugene | Chief Business Officer | P-Purchase | Acquired | 5,250 | $4.76 |
| 20 Jan 2026 | Schall Thomas J. | director | P-Purchase | Acquired | 21,645 | $4.67 |